---
figid: PMC7092730__nihms-1567683-f0001
figlink: pmc/articles/PMC7092730/figure/F1/
number: Fig. 1
caption: Overview of the three adipogenic transdifferentiation pathways. The first
  strategy is to enforce or activate the canonical adipogenic pathway. The ultimate
  goal is to increase the expression level of adipogenic master genes Prdm16, Pparg
  as well as C/EBP. It could be directly manipulating these three genes or through
  indirect activation by chemical compounds (Thiazolidinediones or Bexarotene), molecules
  (EBF2, BMP2, or EHMT1), or microRNAs (miR-193b or miR-133). The second strategy
  is to suppress myogenic program in myoblasts. This strategy mostly focuses on the
  Pax7-MyoD/Myf5 cascade. It has been reported that MyoD acts through E2F4/p107/p130
  regulating axis which in turn upregulates PRDM16. The third strategy involves other
  signaling pathways including DN MKK3, Msx1, Shp2, MAPK, IGF-1, as well as Wnt signaling
  pathways
pmcid: PMC7092730
papertitle: Transdifferentiation of Muscle Satellite Cells to Adipose Cells Using
  CRISPR/Cas9-Mediated Targeting of MyoD.
reftext: Jingjuan Chen, et al. Methods Mol Biol. ;1889:25-41.
pmc_ranked_result_index: '60671'
pathway_score: 0.954679
filename: nihms-1567683-f0001.jpg
figtitle: Three adipogenic transdifferentiation pathways
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7092730__nihms-1567683-f0001.html
  '@type': Dataset
  description: Overview of the three adipogenic transdifferentiation pathways. The
    first strategy is to enforce or activate the canonical adipogenic pathway. The
    ultimate goal is to increase the expression level of adipogenic master genes Prdm16,
    Pparg as well as C/EBP. It could be directly manipulating these three genes or
    through indirect activation by chemical compounds (Thiazolidinediones or Bexarotene),
    molecules (EBF2, BMP2, or EHMT1), or microRNAs (miR-193b or miR-133). The second
    strategy is to suppress myogenic program in myoblasts. This strategy mostly focuses
    on the Pax7-MyoD/Myf5 cascade. It has been reported that MyoD acts through E2F4/p107/p130
    regulating axis which in turn upregulates PRDM16. The third strategy involves
    other signaling pathways including DN MKK3, Msx1, Shp2, MAPK, IGF-1, as well as
    Wnt signaling pathways
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K3
  - MSX1
  - PPARA
  - PPARG
  - PPARD
  - EBP
  - PRDM16
  - PTPN11
  - EBF2
  - MAPK14
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK1
  - MAPK9
  - MAPK10
  - MAK
  - BMP2
  - EHMT1
  - IGF1
  - PAX7
  - MYF5
  - WNT1
  - WNT5A
  - WNT6
  - WNT7A
  - WNT8A
  - WNT8B
  - WNT10B
  - WNT2B
  - WNT16
  - WNT2
  - WNT3
  - WNT7B
  - WNT11
  - WNT9A
  - WNT9B
  - WNT4
  - WNT10A
  - WNT5B
  - WNT3A
  - Thiazolidinediones
  - Bexarotene
genes:
- word: MKK3
  symbol: MKK3
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K3
  entrez: '5606'
- word: Msx1
  symbol: MSX1
  source: hgnc_symbol
  hgnc_symbol: MSX1
  entrez: '4487'
- word: Ppar
  symbol: PPAR
  source: bioentities_symbol
  hgnc_symbol: PPARA
  entrez: '5465'
- word: Ppar
  symbol: PPAR
  source: bioentities_symbol
  hgnc_symbol: PPARG
  entrez: '5468'
- word: Ppar
  symbol: PPAR
  source: bioentities_symbol
  hgnc_symbol: PPARD
  entrez: '5467'
- word: C/EBP
  symbol: EBP
  source: hgnc_symbol
  hgnc_symbol: EBP
  entrez: '10682'
- word: Prdm16
  symbol: PRDM16
  source: hgnc_symbol
  hgnc_symbol: PRDM16
  entrez: '63976'
- word: Shp2
  symbol: SHP2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: EBF2
  symbol: EBF2
  source: hgnc_symbol
  hgnc_symbol: EBF2
  entrez: '64641'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: BMP2
  symbol: BMP2
  source: hgnc_symbol
  hgnc_symbol: BMP2
  entrez: '650'
- word: ΕΗΜΤ1
  symbol: EHMT1
  source: hgnc_symbol
  hgnc_symbol: EHMT1
  entrez: '79813'
- word: IGF-1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: Pax7
  symbol: PAX7
  source: hgnc_symbol
  hgnc_symbol: PAX7
  entrez: '5081'
- word: Pax7*
  symbol: PAX7
  source: hgnc_symbol
  hgnc_symbol: PAX7
  entrez: '5081'
- word: Myf5*
  symbol: MYF5
  source: hgnc_symbol
  hgnc_symbol: MYF5
  entrez: '4617'
- word: Pax7*/Myf5*
  symbol: MYF5
  source: hgnc_symbol
  hgnc_symbol: MYF5
  entrez: '4617'
- word: Pax7
  symbol: PAX7
  source: hgnc_symbol
  hgnc_symbol: PAX7
  entrez: '5081'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: Prdm16
  symbol: PRDM16
  source: hgnc_symbol
  hgnc_symbol: PRDM16
  entrez: '63976'
chemicals:
- word: Thiazolidinediones
  source: MESH
  identifier: D045162
- word: Bexarotene
  source: MESH
  identifier: C095105
diseases: []
---
